Screener
Perspective Therapeutics CATX Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LongTermNotesPayable.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 36,544 | 28,679 |
| Noncurrent liabilities: | ||
| Lease liability, net of current portion | 1,269 | 1,005 |
| Note payable, net of current portion | 1,540 | 1,569 |
| Deferred Income (Note 3) | 26,600 | 26,600 |
| Deferred tax liability | 1,702 | 1,702 |
| Other noncurrent liabilities | 507 | 386 |
| Total liabilities | 68,162 | 59,941 |
ITEM 1 - FINANCIAL STATEMENTS
FAQ
- What is Perspective Therapeutics's long-term debt?
- Perspective Therapeutics (CATX) reported long-term debt of $1.54M in Q2 2026.
- How has Perspective Therapeutics's long-term debt changed year-over-year?
- Perspective Therapeutics's long-term debt decreased by 3.6% year-over-year, from $1.6M to $1.54M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Perspective Therapeutics's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude